Alexander O Vortmeyer Selected Research

Alexander O Vortmeyer Research Topics

Disease

39	Neoplasms (Cancer) 10/2020 - 01/2002
5	Hemangioblastoma 10/2022 - 08/2005
5	von Hippel-Lindau Disease (von Hippel Lindau Disease) 01/2020 - 02/2005
5	Adenoma (Adenomas) 05/2017 - 01/2006
5	Glioma (Gliomas) 01/2016 - 11/2003
4	Glioblastoma (Glioblastoma Multiforme) 03/2020 - 12/2002
4	Hypoxia (Hypoxemia) 01/2020 - 04/2006
4	Carcinogenesis 01/2020 - 01/2003
4	Brain Neoplasms (Brain Tumor) 06/2016 - 05/2007
3	Pituitary Neoplasms (Pituitary Adenoma) 05/2017 - 01/2006
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2011 - 06/2005
3	Pheochromocytoma 06/2007 - 03/2002
3	Multiple Endocrine Neoplasia Type 2a (MEN 2) 06/2007 - 06/2005
3	Cysts 05/2006 - 02/2005
3	Paraganglioma (Paragangliomas) 06/2005 - 03/2002
2	Meningioma (Meningiomas) 10/2016 - 10/2006
2	Leukoencephalopathies 06/2016 - 05/2012
2	Demyelinating Diseases (Demyelinating Disease) 01/2016 - 01/2010
2	Pituitary ACTH Hypersecretion 02/2012 - 09/2009
2	Hyponatremia 12/2011 - 09/2009
2	Hyperplasia 05/2006 - 09/2002
2	Renal Cell Carcinoma (Grawitz Tumor) 08/2005 - 02/2005
1	Pineal Teratoma 10/2020
1	Wilms Tumor (Wilm's Tumor) 10/2020
1	Dystonia (Limb Dystonia) 07/2019
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2018
1	Cryptococcal Meningitis 10/2018
1	Immune Reconstitution Inflammatory Syndrome 10/2018
1	Necrosis 08/2017
1	Acromegaly 05/2017
1	Carney Complex 05/2017
1	Turcot syndrome 01/2017
1	Melanoma (Melanoma, Malignant) 03/2016
1	Neoplasm Metastasis (Metastasis) 03/2016
1	Ear Neoplasms 05/2015
1	Myotonia Congenita (Thomsen Disease) 03/2013
1	Myotonia 03/2013
1	Typical Teratoid Rhabdoid Tumor 10/2012
1	Congenital Abnormalities (Deformity) 10/2012
1	Neuroinflammatory Diseases 01/2012
1	Paralysis (Palsy) 01/2012
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 12/2011
1	Merkel Cell Carcinoma 12/2011
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 12/2011
1	Gigantism 12/2011
1	Thrombosis (Thrombus) 09/2010
1	Diabetes Insipidus 09/2009
1	Ameloblastoma 04/2009
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2009
1	Basal Cell Carcinoma (Rodent Ulcer) 04/2009
1	Disease Progression 01/2009
1	Central Nervous System Diseases (CNS Diseases) 01/2009
1	Lymphoma (Lymphomas) 09/2008

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2004
5	Erythropoietin FDA Link 03/2013 - 11/2003
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 06/2005
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2013 - 09/2005
3	Brachyury protein (Brachyury)IBA 10/2022 - 02/2007
3	ProlactinIBA 05/2017 - 01/2006
3	Capsules (Microcapsules)IBA 09/2009 - 01/2002
3	ProteomeIBA 02/2008 - 08/2006
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 03/2020 - 01/2016
2	Immune Checkpoint InhibitorsIBA 01/2017 - 03/2016
2	EnzymesIBA 10/2016 - 04/2005
2	ErbB Receptors (EGF Receptor)IBA 05/2015 - 05/2007
2	Adrenocorticotropic Hormone (ACTH)FDA Link 02/2012 - 07/2006
2	CatecholaminesIBA 06/2007 - 09/2002
2	Codon (Codons)IBA 05/2006 - 01/2003
2	DNA (Deoxyribonucleic Acid)IBA 01/2003 - 02/2002
1	OligonucleotidesIBA 10/2022
1	RNA (Ribonucleic Acid)IBA 10/2022
1	Temozolomide (Temodar)FDA LinkGeneric 03/2020
1	incobotulinumtoxinA FDA Link 07/2019
1	Amphotericin B (Amphotericin)FDA LinkGeneric 10/2018
1	liposomal amphotericin B FDA Link 10/2018
1	Fatty Acids (Saturated Fatty Acids)IBA 08/2017
1	AntioxidantsIBA 08/2017
1	Growth Hormone (Somatotropin)IBA 05/2017
1	RNA Polymerase II (RNA Polymerase B)IBA 10/2016
1	Monoclonal AntibodiesIBA 06/2016
1	Immunomodulating AgentsIBA 03/2016
1	pembrolizumabIBA 03/2016
1	IpilimumabIBA 01/2016
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 03/2013
1	ChloridesIBA 03/2013
1	Nitric Oxide Synthase (NO Synthase)IBA 03/2013
1	Chloride Channels (Chloride Channel)IBA 03/2013
1	Neuroprotective AgentsIBA 01/2012
1	Vasopressins (Vasopressin)IBA 12/2011
1	salicylhydroxamic acid (SHAM)IBA 09/2010
1	ElectrolytesIBA 09/2009
1	Ber-EP4 monoclonal antibodyIBA 04/2009

Therapy/Procedure

10	Therapeutics 10/2020 - 12/2002
3	Drug Therapy (Chemotherapy) 01/2017 - 11/2003
3	Radiotherapy 01/2017 - 12/2002
2	Hypophysectomy 05/2017 - 07/2012
2	Immunotherapy 06/2016 - 03/2016
1	Aftercare (After-Treatment) 06/2016
1	Laminectomy 10/2012
1	Osteotomy 10/2012